Simplex Trading’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
50,500
+49,800
+7,114% +$900K ﹤0.01% 2543
2026
Q1
$12.2K Buy
700
+200
+40% +$3.85K ﹤0.01% 7168
2025
Q4
$6.62K Sell
500
-500
-50% -$4.43K ﹤0.01% 7264
2025
Q3
$5K Buy
+1,000
New +$4.68K ﹤0.01% 8362

Other funds holding BIOA

Simplex Trading's BIOA Position: Q2 2026 in Review

Simplex Trading increased its BioAge Labs (BIOA) stake by 1,936% in Q2 2026, buying an estimated $812K and bringing the position to 47,280 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2622.

Simplex Trading first reported a position in BIOA in Q1 2025 and has held it in 6 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Simplex Trading held 47,280 shares of BioAge Labs worth $1.16M as of Q2 2026.
  • Simplex Trading bought 44,958 BioAge Labs shares in Q2 2026, an estimated $812K.
  • BioAge Labs made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #2622 holding.
  • Simplex Trading first reported a position in BioAge Labs in Q1 2025 and has held it in 6 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.